{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Antibiotic resistance", "Antisepsis", "Disinfectant", "Endophthalmitis", "Ocular surgery", "Public health", "Risk management"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36719608", "DateRevised": {"Year": "2023", "Month": "07", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "01", "Day": "31"}], "ELocationID": ["10.1007/s40123-023-00661-9"], "Journal": {"ISSN": "2193-8245", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Apr"}}, "Title": "Ophthalmology and therapy", "ISOAbbreviation": "Ophthalmol Ther"}, "ArticleTitle": "Prophylaxis of Ocular Infection in the Setting of Intraocular Surgery: Implications for Clinical Practice and Risk Management.", "Pagination": {"StartPage": "721", "EndPage": "734", "MedlinePgn": "721-734"}, "Abstract": {"AbstractText": ["In this review we discuss the role of intraocular surgery preoperative prophylaxis. The correct choice of antimicrobial drug is variable in each surgical setting, according to the available strengths of evidence, the anatomical district involved, and the type of procedure. In the ophthalmic surgical field, there has been a progressive shift from antibiotic formulations, which are known to cause antibiotic resistance, to a new class of antiseptic compounds, which proved to be effective not only against bacteria, but also against fungi, protozoa, and viruses. Among these, povidone-iodine (PVI) is a water-soluble polymer that can form a complex with iodine, and the perioperative application of PVI 5-10% eye drop for 3\u00a0min is the gold standard for infection prophylaxis. A new formulation of 0.6% PVI eye drop is a new option for infection prophylaxis in the days before surgery. Chlorhexidine is a biguanide compound, which is a valid alternative with a good safety and efficacy profile and is the antiseptic of choice in patients with iodine allergy. New compounds that are currently being studied include polyhexamethylene biguanide (PHMB), picloxydine, ozone, hypochlorous acid (HOCl), and Biosecur. PHMB is a biguanide polymer that was found to be more effective than PVI in in\u00a0vitro studies for reducing microorganisms and extending the duration of antisepsis, but to date, there are no formulations available on the market for preoperative ocular surgery in which it is present as main ingredient. Ozone is a molecule with oxidizing effect, which showed interesting preliminary results but is not effective against virus, Staphylococcus\u00a0aureus and Candida\u00a0albicans. HOCl has a natural bactericidal propriety but its applicability to prophylaxis of ocular infection in the setting of ocular surgery is not established. Biosecur is a non-toxic organic alcohol-free compound that exhibited bactericidal and fungicidal effect versus all common microorganisms and is currently available as an ocular spray."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Eye Unit, Humanitas-Gradenigo Hospital, Turin, Italy."}, {"Identifier": [], "Affiliation": "Department of Corneal Diseases, Royal Liverpool University Hospital, Liverpool, UK."}], "LastName": "Borgia", "ForeName": "Alfredo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical and Medical Sciences, University 'Magna Gr\u00e6cia' of Catanzaro, Viale Europa, 88100, Catanzaro, Italy."}], "LastName": "Mazzuca", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgical and Medical Sciences, University 'Magna Gr\u00e6cia' of Catanzaro, Viale Europa, 88100, Catanzaro, Italy."}], "LastName": "Della Corte", "ForeName": "Marcello", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Law, Forensic Medicine and Criminology, University 'Magna Gr\u00e6cia' of Catanzaro, Viale Europa, 88100, Catanzaro, Italy."}], "LastName": "Gratteri", "ForeName": "Nicola", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy."}], "LastName": "Fossati", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy."}], "LastName": "Raimondi", "ForeName": "Raffaele", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Corneal Diseases, Royal Liverpool University Hospital, Liverpool, UK."}], "LastName": "Pagano", "ForeName": "Luca", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, University \"Magna Gr\u00e6cia\" of Catanzaro, Viale Europa, 88100, Germaneto, Catanzaro, Italy."}], "LastName": "Scorcia", "ForeName": "Vincenzo", "Initials": "V"}, {"Identifier": ["0000-0003-2617-0289"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Ophthalmology, University \"Magna Gr\u00e6cia\" of Catanzaro, Viale Europa, 88100, Germaneto, Catanzaro, Italy. giuseppe.giannaccare@unicz.it."}], "LastName": "Giannaccare", "ForeName": "Giuseppe", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Ophthalmol Ther", "NlmUniqueID": "101634502"}, "CommentsCorrectionsList": [{"RefSource": "Ophthalmol Ther. 2023 Apr;12(2):735. doi: 10.1007/s40123-023-00682-4", "PMID": "36808606"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13\u201324. doi: 10.1016/S0161-6420(01)00899-5.", "ArticleIdList": ["10.1016/S0161-6420(01)00899-5", "11772573"]}, {"Citation": "Haripriya A, Baam ZR, Chang DF. Endophthalmitis prophylaxis for cataract surgery. Asia Pac J Ophthalmol (Phila) 2017;6(4):324\u2013329.", "ArticleIdList": ["28780782"]}, {"Citation": "Behndig A, Cochener-Lamard B, G\u00fcell J, Kodjikian L, Mencucci R, Nuijts R, et al. Surgical, antiseptic, and antibiotic practice in cataract surgery: results from the European Observatory in 2013. J Cataract Refract Surg. 2015;41:2635\u20132643. doi: 10.1016/j.jcrs.2015.06.031.", "ArticleIdList": ["10.1016/j.jcrs.2015.06.031", "26796444"]}, {"Citation": "Behnding A, Ravindran R, Flynn H, Relhan N, Hernandez-Camarena J, Valdez-Garcia J, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns around the world. Curr Pharm Des. 2017;23:565\u2013573. doi: 10.2174/1381612822666161216122230.", "ArticleIdList": ["10.2174/1381612822666161216122230", "27981903"]}, {"Citation": "Carrim ZI, Mackie G, Gallacher G, Wykes WN. The efficacy of 5% povidone-iodine for 3 minutes prior to cataract surgery. Eur J Ophthalmol. 2009;19(4):560\u2013564. doi: 10.1177/112067210901900407.", "ArticleIdList": ["10.1177/112067210901900407", "19551669"]}, {"Citation": "Wu PC, Li M, Chang SJ, et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone- iodine preoperative disinfection. J Ocul Pharmacol Ther. 2006;22(1):54\u201361. doi: 10.1089/jop.2006.22.54.", "ArticleIdList": ["10.1089/jop.2006.22.54", "16503776"]}, {"Citation": "Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery: iii. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728\u2013729. doi: 10.1001/archopht.1984.01040030584025.", "ArticleIdList": ["10.1001/archopht.1984.01040030584025", "6721765"]}, {"Citation": "Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639\u2013650. doi: 10.1016/S0161-6420(91)32239-5.", "ArticleIdList": ["10.1016/S0161-6420(91)32239-5", "2062496"]}, {"Citation": "Barry P, Gettinby G, Lees F, Peterson M, Revie C, Seal D, et al. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978\u2013988. doi: 10.1016/j.jcrs.2007.02.032.", "ArticleIdList": ["10.1016/j.jcrs.2007.02.032", "17531690"]}, {"Citation": "Groden LR, Murphy B, Rodnite J, Genvert GI. Lid flora in blepharitis. Cornea. 1991;10:50\u201353. doi: 10.1097/00003226-199110010-00010.", "ArticleIdList": ["10.1097/00003226-199110010-00010", "2019106"]}, {"Citation": "Barry P, Cordov\u00e9s L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: prevention & treatment endophthalmitis. [cited 2022 Dec 14]; www.escrs.org. Accessed 15 Nov 2022."}, {"Citation": "Li B, Nentwich MM, Hoffmann LE, Haritoglou C, Kook D, Kampik A, et al. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery. J Cataract Refract Surg. 2013;39:994\u20131001. doi: 10.1016/j.jcrs.2013.02.039.", "ArticleIdList": ["10.1016/j.jcrs.2013.02.039", "23680628"]}, {"Citation": "Mi\u00f1o de Kaspar H, Kreutzer TC, Aguirre-Romo I, Ta CN, Dudichum J, Bayrhof M, et al. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol. 2008;145:136\u2013142.e2. doi: 10.1016/j.ajo.2007.08.031.", "ArticleIdList": ["10.1016/j.ajo.2007.08.031", "17996212"]}, {"Citation": "He L, Ta CN, Hu N, SinnarMi\u00f1 de Kaspar SH. Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. J Ocul Pharmacol Ther. 2009;25(4):373\u2013378. doi: 10.1089/jop.2008.0102.", "ArticleIdList": ["10.1089/jop.2008.0102", "19492956"]}, {"Citation": "Moss JM, Nguyen D, Liu YI, Singh K, Montague A, Egbert PR, et al. Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology. 2008;115:2013\u20132016. doi: 10.1016/j.ophtha.2008.06.024.", "ArticleIdList": ["10.1016/j.ophtha.2008.06.024", "18708260"]}, {"Citation": "Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116:1498\u20131501. doi: 10.1016/j.ophtha.2009.02.024.", "ArticleIdList": ["10.1016/j.ophtha.2009.02.024", "19501409"]}, {"Citation": "Halachimi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg. 2009;35:2109\u20132114. doi: 10.1016/j.jcrs.2009.06.038.", "ArticleIdList": ["10.1016/j.jcrs.2009.06.038", "19969216"]}, {"Citation": "Friling E, Lundstr\u00f6m M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39:15\u201321. doi: 10.1016/j.jcrs.2012.10.037.", "ArticleIdList": ["10.1016/j.jcrs.2012.10.037", "23245359"]}, {"Citation": "Miller D. Update on the epidemiology and antibiotic resistance of ocular infections. Middle East Afr J Ophthalmol. 2017;24:30\u201342.", "ArticleIdList": ["PMC5433126", "28546690"]}, {"Citation": "Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology. 2012;119:1420\u20131424. doi: 10.1016/j.ophtha.2012.01.016.", "ArticleIdList": ["10.1016/j.ophtha.2012.01.016", "22420958"]}, {"Citation": "Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147\u2013179. doi: 10.1128/CMR.12.1.147.", "ArticleIdList": ["10.1128/CMR.12.1.147", "PMC88911", "9880479"]}, {"Citation": "Eggers M, Koburger-Janssen T, Ward LS, Newby C, M\u00fcller S. Bactericidal and virucidal activity of povidone-iodine and chlorhexidine gluconate cleansers in an in vivo hand hygiene clinical simulation study. Infect Dis Ther. 2018;7:235\u2013247. doi: 10.1007/s40121-018-0202-5.", "ArticleIdList": ["10.1007/s40121-018-0202-5", "PMC5986686", "29761329"]}, {"Citation": "Grzybowski A, Brona P, Kim SJ. Microbial flora and resistance in ophthalmology: a review. Graefe\u2019s Arch Clin Exp Ophthalmol. 2017;255:851\u2013862. doi: 10.1007/s00417-017-3608-y.", "ArticleIdList": ["10.1007/s00417-017-3608-y", "PMC5394129", "28229218"]}, {"Citation": "Saggers BA, Stewart GT. Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity. Epidemiol Infect. 1964;62:509\u2013518. doi: 10.1017/S0022172400040225.", "ArticleIdList": ["10.1017/S0022172400040225", "PMC2134614", "14239927"]}, {"Citation": "Chou SF, Lin CH, Chang SW. Povidone\u2013iodine application induces corneal cell death through fixation. Br J Ophthalmol. 2011;95:277\u2013283. doi: 10.1136/bjo.2010.189407.", "ArticleIdList": ["10.1136/bjo.2010.189407", "21036788"]}, {"Citation": "Ricciardelli G, Giannaccare G, di Zazzo A, Coassin M, Scorcia V, Romano MR, et al. Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a prospective randomized controlled study. Eye. 2021;36:160\u2013166. doi: 10.1038/s41433-020-01344-6.", "ArticleIdList": ["10.1038/s41433-020-01344-6", "PMC8727611", "33654316"]}, {"Citation": "Ta CN, Singh K, Egbert PR, de Kaspar HM. Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery. J Cataract Refract Surg. 2008;34:171\u2013172. doi: 10.1016/j.jcrs.2007.08.035.", "ArticleIdList": ["10.1016/j.jcrs.2007.08.035", "18165101"]}, {"Citation": "Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769\u20131775. doi: 10.1016/S0161-6420(91)32052-9.", "ArticleIdList": ["10.1016/S0161-6420(91)32052-9", "1775308"]}, {"Citation": "Alp BN, Elibol O, Sargon MF, Aslan OS, Yanyali A, Karabas L, et al. The effect of povidone iodine on the corneal endothelium. Cornea. 2000;19:546\u2013550. doi: 10.1097/00003226-200007000-00028.", "ArticleIdList": ["10.1097/00003226-200007000-00028", "10928775"]}, {"Citation": "Binder CA, Miaeo De Kaspar H, Klau\u00fb V, Kampik A, Binder CA, Bender CA, et al. Preoperative infection prophylaxis with 1 % polyvidon-iodine solution based on the example of conjunctival staphylococci. Ophthalmologe. 1999;96:663\u2013667. doi: 10.1007/s003470050471.", "ArticleIdList": ["10.1007/s003470050471", "10552160"]}, {"Citation": "Shimada H, Arai S, Nakashizuka H, Hattori T, Yuzawa M. Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone\u2013iodine. Am J Ophthalmol. 2011;151:11\u201317.e1. doi: 10.1016/j.ajo.2010.07.002.", "ArticleIdList": ["10.1016/j.ajo.2010.07.002", "20970112"]}, {"Citation": "Jiang J, Wu M, Shen T. The toxic effect of different concentrations of povidone iodine on the rabbit's cornea. Cutan Ocul Toxicol. 2009;28(3):119\u2013124. doi: 10.1080/15569520903080511.", "ArticleIdList": ["10.1080/15569520903080511", "19694608"]}, {"Citation": "Ahmed Y, Scott IU, Pathengay A, Bawdekar A, Flynn HW. Povidone-iodine for endophthalmitis prophylaxis. Am J Ophthalmol. 2014;157:503\u2013504. doi: 10.1016/j.ajo.2013.12.001.", "ArticleIdList": ["10.1016/j.ajo.2013.12.001", "24528933"]}, {"Citation": "Peden MC, Hammer ME, Su\u00f1er IJ. Dilute povidone-iodine prophylaxis maintains safety while improving patient comfort after intravitreal injections. Retina. 2019;39:2219\u20132224. doi: 10.1097/IAE.0000000000002290.", "ArticleIdList": ["10.1097/IAE.0000000000002290", "30142109"]}, {"Citation": "Musumeci R, Troiano P, Martinelli M, Piovella M, Carbonara C, Rossi S, et al. Effectiveness of 0.66% povidone-iodine eye drops on ocular surface flora before cataract surgery: a nationwide microbiological study. Jo Clin Med. 2021;10:2198. doi: 10.3390/jcm10102198.", "ArticleIdList": ["10.3390/jcm10102198", "PMC8160713", "34069600"]}, {"Citation": "Pinna A, Donadu MG, Usai D, Dore S, D\u2019Amico-Ricci G, Boscia F, et al. In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM\u00ae) Acta Ophthalmol. 2020;98:e178\u2013e180. doi: 10.1111/aos.14243.", "ArticleIdList": ["10.1111/aos.14243", "31486592"]}, {"Citation": "Reibaldi M, Avitabile T, Bandello F, Longo A, Bonfiglio V, Russo A, et al. The effectiveness of 0.6% povidone iodine eye drops in reducing the conjunctival bacterial load and needle contamination in patients undergoing anti-VEGF intravitreal injection: a prospective, randomized study. J Clin Med. 2019;8:1031. doi: 10.3390/jcm8071031.", "ArticleIdList": ["10.3390/jcm8071031", "PMC6678890", "31337003"]}, {"Citation": "Tognetto D, Pastore MR, Belfanti L, Merli R, Vinciguerra AL, Busetti M, et al. In vivo antimicrobial activity of 0.6% povidone-iodine eye drops in patients undergoing intravitreal injections: a prospective study. Sci Rep. 2021;11:1\u20136. doi: 10.1038/s41598-021-02831-w.", "ArticleIdList": ["10.1038/s41598-021-02831-w", "PMC8639677", "34857862"]}, {"Citation": "Hidalgo E, Dominguez C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro. 2001;15:271\u2013276. doi: 10.1016/S0887-2333(01)00020-0.", "ArticleIdList": ["10.1016/S0887-2333(01)00020-0", "11566548"]}, {"Citation": "Jenkins S, Addy M, Wade W. The mechanism of action of chlorhexidine. J Clin Periodontol. 1988;15:415\u2013424. doi: 10.1111/j.1600-051X.1988.tb01595.x.", "ArticleIdList": ["10.1111/j.1600-051X.1988.tb01595.x", "3183067"]}, {"Citation": "Karpi\u0144ski TM, Szkaradkiewicz AK. Chlorhexidine\u2013pharmaco-biological activity and application. Eur Rev Med Pharmacol Sci. 2015;19(7):1321\u20131326.", "ArticleIdList": ["25912596"]}, {"Citation": "Merani R, McPherson ZE, Luckie AP, Gilhotra JS, Runciman J, Durkin S, et al. Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature. Ophthalmology. 2016;123:2588\u20132594. doi: 10.1016/j.ophtha.2016.08.022.", "ArticleIdList": ["10.1016/j.ophtha.2016.08.022", "27720552"]}, {"Citation": "Oakley CL, Vote BJ. Aqueous chlorhexidine (0.1%) is an effective alternative to povidone\u2013iodine for intravitreal injection prophylaxis. Acta Ophthalmol. 2016;94:e808\u2013e809. doi: 10.1111/aos.12981.", "ArticleIdList": ["10.1111/aos.12981", "26947261"]}, {"Citation": "Dossarps D, Bron AM, Koehrer P, Aho-Gl\u00e9l\u00e9 LS, Creuzot-Garcher C, Berthon L, et al. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol. 2015;160:17\u201325.e1. doi: 10.1016/j.ajo.2015.04.013.", "ArticleIdList": ["10.1016/j.ajo.2015.04.013", "25892127"]}, {"Citation": "Tabor E, Bostwick DC, Evans CC. Corneal damage due to eye contact with chlorhexidine gluconate. JAMA. 1989;261:557\u2013558. doi: 10.1001/jama.1989.03420040091021.", "ArticleIdList": ["10.1001/jama.1989.03420040091021", "2909794"]}, {"Citation": "Varley GA, Meisler DM, Benes SC, McMahon JT, Zakov ZN, Fryczkowski A. Hibiclens keratopathy. A clinicopathologic case report. Cornea. 1990;9:341\u2013346. doi: 10.1097/00003226-199010000-00014.", "ArticleIdList": ["10.1097/00003226-199010000-00014", "2078964"]}, {"Citation": "Behndig A, Montan P, Stenevi U, Kugelberg M, Lundstr\u00f6m M. One million cataract surgeries: Swedish National Cataract Register 1992\u20132009. J Cataract Refract Surg. 2011;37:1539\u20131545. doi: 10.1016/j.jcrs.2011.05.021.", "ArticleIdList": ["10.1016/j.jcrs.2011.05.021", "21782099"]}, {"Citation": "Behndig A, Cochener B, G\u00fcell JL, Kodjikian L, Mencucci R, Nuijts RMMA, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421\u20131431. doi: 10.1016/j.jcrs.2013.06.014.", "ArticleIdList": ["10.1016/j.jcrs.2013.06.014", "23988244"]}, {"Citation": "Tognetto D, Pastore MR, Guerin GM, Decorti G, Franzin M, Lagatolla C, et al. Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis. Graefe\u2019s Arch Clin Exp Ophthalmol. 2022;260:289\u2013293. doi: 10.1007/s00417-021-05361-3.", "ArticleIdList": ["10.1007/s00417-021-05361-3", "PMC8763824", "34427741"]}, {"Citation": "Caruso C, Eletto D, Tosco A, Pannetta M, Scarinci F, Troisi M, et al. Comparative evaluation of antimicrobial, antiamoebic, and antiviral efficacy of ophthalmic formulations. Microorganisms. 2022;10:1156. doi: 10.3390/microorganisms10061156.", "ArticleIdList": ["10.3390/microorganisms10061156", "PMC9229167", "35744674"]}, {"Citation": "Mulder GD, Cavorsi JP, Lee DK. Polyhexamethylene biguanide (PHMB): an addendum to current topical antimicrobials. Wounds. 2007;19:173\u2013182.", "ArticleIdList": ["26110333"]}, {"Citation": "Chindera K, Mahato M, Kumar Sharma A, Horsley H, Kloc-Muniak K, Kamaruzzaman NF, et al. The antimicrobial polymer PHMB enters cells and selectively condenses bacterial chromosomes. Sci Rep. 2016;6:1\u201313. doi: 10.1038/srep23121.", "ArticleIdList": ["10.1038/srep23121", "PMC4800398", "26996206"]}, {"Citation": "Wessels S, Ingmer H. Modes of action of three disinfectant active substances: a review. Regul Toxicol Pharmacol. 2013;67:456\u2013467. doi: 10.1016/j.yrtph.2013.09.006.", "ArticleIdList": ["10.1016/j.yrtph.2013.09.006", "24080225"]}, {"Citation": "Gilbert P, Pemberton D, Wilkinson DE. Synergism within polyhexamethylene biguanide biocide formulations. J Appl Bacteriol. 1990;69:593\u2013598. doi: 10.1111/j.1365-2672.1990.tb01553.x.", "ArticleIdList": ["10.1111/j.1365-2672.1990.tb01553.x", "2292523"]}, {"Citation": "Mafra CSP, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, de Taguchi FMC, Foronda AS, de Carvalho FRS, et al. Antimicrobial action of biguanides on the viability of acanthamoeba cysts and assessment of cell toxicity. Invest Ophthalmol Vis Sci. 2013;54:6363\u20136372. doi: 10.1167/iovs.13-11990.", "ArticleIdList": ["10.1167/iovs.13-11990", "23900604"]}, {"Citation": "Forstner C, Leitgeb J, Schuster R, Dosch V, Kramer A, Cutting KF, et al. Bacterial growth kinetics under a novel flexible methacrylate dressing serving as a drug delivery vehicle for antiseptics. Int J Mol Sci. 2013;14:10582\u201310590. doi: 10.3390/ijms140510582.", "ArticleIdList": ["10.3390/ijms140510582", "PMC3676855", "23698780"]}, {"Citation": "Gilbert P, Das JR, Jones Mv, Allison DG. Assessment of resistance towards biocides following the attachment of micro-organisms to, and growth on, surfaces. J Appl Microbiol. 2001;91:248\u2013254. doi: 10.1046/j.1365-2672.2001.01385.x.", "ArticleIdList": ["10.1046/j.1365-2672.2001.01385.x", "11473589"]}, {"Citation": "Kramer A, Roth B, M\u00fcller G, Rudolph P, Kl\u00f6cker N. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. Skin Pharmacol Physiol. 2004;17:141\u2013146. doi: 10.1159/000077241.", "ArticleIdList": ["10.1159/000077241", "15087593"]}, {"Citation": "Papa V, van der Meulen I, Rottey S, Sallet G, Overweel J, Asero N, et al. Safety and tolerability of topical polyhexamethylene biguanide: a randomised clinical trial in healthy adult volunteers. Br J Ophthalmol. 2022;106:190\u2013196. doi: 10.1136/bjophthalmol-2020-317848.", "ArticleIdList": ["10.1136/bjophthalmol-2020-317848", "33239413"]}, {"Citation": "Hansmann F, Kramer A, Ohgke H, Strobel H, M\u00fcller M, Geerling G. Lavasept\u00ae as an alternative to PVP-iodine for preoperative desinfection in ophthalmic surgery: randomized, controlled, prospective double-blind trial. Ophthalmologe. 2005;102:1043\u20131050. doi: 10.1007/s00347-004-1120-3.", "ArticleIdList": ["10.1007/s00347-004-1120-3", "16283191"]}, {"Citation": "Ristau T, Kirchhof B, Fauser S. Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections. Acta Ophthalmol. 2014;92:e494\u2013e496. doi: 10.1111/aos.12347.", "ArticleIdList": ["10.1111/aos.12347", "24460667"]}, {"Citation": "Budzinskaya Mv, Khalatyan AS, Strakhovskaya MG, Zhukhovitsky VG. Ocular flora in patients undergoing intravitreal injections: antibiotic resistance patterns and susceptibility to antiseptic picloxydine. Int J Ophthalmol. 2020;13:85\u201392. doi: 10.18240/ijo.2020.01.13.", "ArticleIdList": ["10.18240/ijo.2020.01.13", "PMC6942944", "31956575"]}, {"Citation": "Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based eye drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol. 2018;9:287\u2013298. doi: 10.1159/000488846.", "ArticleIdList": ["10.1159/000488846", "PMC6006625", "29928225"]}, {"Citation": "Marchegiani A, Magagnini M, Cerquetella M, Troiano P, Franchini I, Franchini A, et al. Preoperative topical liposomal ozone dispersion to reduce bacterial colonization in conjunctival sac and periocular skin: preliminary study in dogs. Exp Eye Res. 2019;189:107848. doi: 10.1016/j.exer.2019.107848.", "ArticleIdList": ["10.1016/j.exer.2019.107848", "31634477"]}, {"Citation": "Celenza G, Iorio R, Cracchiolo S, Petricca S, Costagliola C, Cinque B, et al. Antimycotic activity of ozonized oil in liposome eye drops against Candida spp. Transl Vis Sci Technol. 2020;9:4\u20134. doi: 10.1167/tvst.9.8.4.", "ArticleIdList": ["10.1167/tvst.9.8.4", "PMC7422790", "32855851"]}, {"Citation": "P\u00e9rez-Santonja JJ, G\u00fcell JL, Gris O, Dorrego XMV, Pellicer E, Ben\u00edtez-Del-castillo JM. Liposomal ozonated oil in ocular infections: a review of preclinical and clinical studies, focusing on its antiseptic and regenerative properties. Clin Ophthalmol. 2022;16:1953\u20131962. doi: 10.2147/OPTH.S360929.", "ArticleIdList": ["10.2147/OPTH.S360929", "PMC9206455", "35726319"]}, {"Citation": "Spadea L, Zanotto E, Cavallo R, Campagna G, Giannico MI, Costagliola C. Effectiveness of liposomal ozonized oil in reducing ocular microbial flora in patients undergoing cataract surgery. J Cataract Refract Surg. 2021;47:1548\u20131555. doi: 10.1097/j.jcrs.0000000000000672.", "ArticleIdList": ["10.1097/j.jcrs.0000000000000672", "33974370"]}, {"Citation": "Bertone C, Mollicone A, Russo S, Sasso P, Fasciani R, Riccardi C, et al. The role of hypochlorous acid in the management of eye infections: a case series. Drugs Context. 2022;11:1\u20138. doi: 10.7573/dic.2022-3-10.", "ArticleIdList": ["10.7573/dic.2022-3-10", "PMC9267159", "35865000"]}, {"Citation": "Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous acid: an ideal wound care agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26:342\u2013350.", "ArticleIdList": ["25785777"]}, {"Citation": "Klocek MS, Mammen A, Dhaliwal D, Kowalski RP. Time-kill comparison of povidone iodine to hypochlorous acid against endophthalmitis isolates of staphylococci. Invest Ophthalmol Vis Sci. 2016;57:5861\u20135861."}, {"Citation": "Kanclerz P, Grzybowski A, Olszewski B. Low efficacy of hypochlorous acid solution compared to povidone-iodine in cataract surgery antisepsis. Open Ophthalmol J. 2019;13:29\u201333. doi: 10.2174/1874364101913010029.", "ArticleIdList": ["10.2174/1874364101913010029"]}, {"Citation": "Hypochlorous acid disinfection prior to cataract surgery - Full Text View - ClinicalTrials.gov. [cited 2022 Dec 14]. https://clinicaltrials.gov/ct2/show/NCT04568213. Accessed 15 Nov 2022."}, {"Citation": "Mencucci R, Ghelardi E, Celandroni F, Mazzantini C, Vecchione A, Pellegrini-Giampietro DE, et al. Antiseptics and the ocular surface: in vitro antimicrobial activity and effects on conjunctival and corneal epithelial cells of a new liposomal ocular spray containing Biosecur\u00ae citrus extract. Ophthalmol Ther. 2022;11:1067\u20131077. doi: 10.1007/s40123-022-00492-0.", "ArticleIdList": ["10.1007/s40123-022-00492-0", "PMC9114213", "35284982"]}, {"Citation": "Vagge A, Ferro Desideri L, Carnevali A, del Noce C, Camposampiero D, Agrusta M, et al. Efficacy of a new commercial ocular spray containing oftasecur citrus extract for reducing microbial load in the conjunctiva of patients receiving intravitreal injections. Ophthalmol Ther. 2021;10:1025\u20131032. doi: 10.1007/s40123-021-00384-9.", "ArticleIdList": ["10.1007/s40123-021-00384-9", "PMC8589878", "34495493"]}, {"Citation": "Hernandez-Bogantes E, Navas A, Naranjo A, Amescua G, Graue-Hernandez EO, Flynn HW, et al. Toxic anterior segment syndrome: a review. Surv Ophthalmol. 2019;64:463\u2013476. doi: 10.1016/j.survophthal.2019.01.009.", "ArticleIdList": ["10.1016/j.survophthal.2019.01.009", "30703402"]}, {"Citation": "Jun EJ, Chung SK. Toxic anterior segment syndrome after cataract surgery. J Cataract Refract Surg. 2010;36:344\u2013346. doi: 10.1016/j.jcrs.2009.07.052.", "ArticleIdList": ["10.1016/j.jcrs.2009.07.052", "20152620"]}, {"Citation": "Yang S, Yan X. Retrospective analysis of clinical characteristics of toxic anterior segment syndrome. Zhonghua Yan Ke Za Zhi. 2009;45:225\u2013228.", "ArticleIdList": ["19575916"]}, {"Citation": "Parikh SR, Parikh RS. Chemical disinfectants in ophthalmic practice. Indian J Ophthalmol. 2021;69:510. doi: 10.4103/ijo.IJO_1549_20.", "ArticleIdList": ["10.4103/ijo.IJO_1549_20", "PMC7942131", "33595464"]}, {"Citation": "Bollero D, Cortellini M, Stella M, et\u00a0al. Pan-antibiotic resistance and nosocomial infection in burn patients: therapeutic choices and medico-legal problems in Italy. Ann Burns Fire Disasters. 2003; p. 182\u20137."}, {"Citation": "Treglia M, Pallocci M, Passalacqua P, Giammatteo J, de Luca L, Mauriello S, et al. Medical liability: review of a whole year of judgments of the civil court of Rome. Int J Environ Res Public Health. 2021;18:6019. doi: 10.3390/ijerph18116019.", "ArticleIdList": ["10.3390/ijerph18116019", "PMC8199932", "34205091"]}, {"Citation": "Treglia M, Pallocci M, Passalacqua P, Sabatelli G, de Luca L, Zanovello C, et al. Medico-legal aspects of hospital-acquired infections: 5-years of judgements of the civil court of Rome. Healthcare. 2022;10:1336. doi: 10.3390/healthcare10071336.", "ArticleIdList": ["10.3390/healthcare10071336", "PMC9322800", "35885861"]}, {"Citation": "Infezioni ospedaliere: cause e prevenzione - ISSalute [Internet]. [cited 2022 Dec 14]. https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/i/infezioni-ospedaliere%23link-di-approfondimento. Accessed 15 Nov 2022."}, {"Citation": "Gouv\u00eaa M, de Novaes CO, Pereira DMT, Iglesias AC. Adherence to guidelines for surgical antibiotic prophylaxis: a review. Braz J Infect Dis. 2015;19:517\u2013524. doi: 10.1016/j.bjid.2015.06.004.", "ArticleIdList": ["10.1016/j.bjid.2015.06.004", "PMC9427538", "26254691"]}, {"Citation": "Zaharia A-C, Dumitrescu O-M, Rogoz R-E, Dimirache AE, Zemba M. Preoperative antisepsis in ophthalmic surgery (a review) Rom J Ophthalmol. 2021;65:120. doi: 10.22336/rjo.2021.25.", "ArticleIdList": ["10.22336/rjo.2021.25", "PMC8207863", "34179575"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "18"}, {"Year": "2023", "Month": "1", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "31", "Hour": "11", "Minute": "22"}, {"Year": "2023", "Month": "1", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36719608", "PMC10011360", "10.1007/s40123-023-00661-9", "10.1007/s40123-023-00661-9"]}}], "PubmedBookArticle": []}